1 Introduction (Page No. - 14)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2 Research Methodology (Page No. - 17)
2.1 Research Methodology Steps
2.2 Secondary and Primary Research Methodology
2.2.1 Secondary Research
2.2.1.1 Key Data From Secondary Sources
2.2.2 Primary Research
2.2.2.1 Key Data From Primary Sources
2.2.2.2 Key Insights From Primary Sources
2.2.2.3 Key Industry Insights
2.3 Market Size Estimation Methodology
2.4 Market Data Validation and Triangulation
2.5 Assumptions for the Study
3 Executive Summary (Page No. - 28)
3.1 Introduction
3.2 Conclusion
4 Premium Insights (Page No. - 32)
4.1 Extracorporeal Membrane Oxygenation (ECMO) Machine: Market Overview
4.2 Geographic Analysis: ECMO Machine Market, By Modality (2016)
4.3 ECMO Machine Market, By Application, 2016 vs 2021
4.4 Geographic Snapshot of the ECMO Machine Market
5 Market Overview (Page No. - 35)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Prevalence of Cardiovascular and Respiratory Diseases
5.2.1.2 Growing Adoption of ECMO in Lung Transplantation Procedures
5.2.1.3 Growth in the Number of ECMO Centers
5.2.1.4 Technological Advancements in ECMO Machine
5.2.2 Restraints
5.2.2.1 Complications Associated With ECMO
5.2.2.2 High Cost of ECMO Procedures
5.2.3 Opportunities
5.2.3.1 Increasing Survival Rates With ECMO
5.2.4 Challenges
5.2.4.1 Lack of Skilled Professionals
6 Global Extracorporeal Membrane Oxygenation Machine Market, By Modality (Page No. - 42)
6.1 Introduction
6.2 Venovenous ECMO
6.3 Venoarterial ECMO
6.4 Arteriovenous ECMO
7 Global Extracorporeal Membrane Oxygenation Machine Market, By Application (Page No. - 49)
7.1 Introduction
7.2 Respiratory Applications
7.2.1 Neonates
7.2.2 Pediatrics
7.2.3 Adults
7.3 Cardiac Applications
7.3.1 Adults
7.3.2 Pediatrics
7.3.3 Neonates
7.4 Extracorporeal Cardiopulmonary Resuscitation (ECPR)
7.4.1 Neonates
7.4.2 Pediatrics
7.4.3 Adults
8 Extracorporeal Membrane Oxygenation Machine Market, By Region (Page No. - 61)
8.1 Introduction
8.2 North America
8.2.1 U.S.
8.2.1.1 Rising Healthcare Spending
8.2.1.2 Rise in Geriatric Population, Prevalence of Cardiovascular Diseases
8.2.1.3 Increase in Research Studies
8.2.2 Canada
8.2.2.1 Implementation of A New Funding Model in Canadian Hospitals
8.2.2.2 Conferences to Increase Awareness
8.3 Europe
8.3.1 Germany
8.3.1.1 Increasing Volume of ECMO Procedures in Germany
8.3.2 U.K.
8.3.2.1 Rising Adoption of ECMO Procedures
8.3.3 France
8.3.3.1 Rising Healthcare Spending
8.3.4 Rest of Europe
8.3.4.1 Decreasing Number of Cardiovascular Deaths in Spain
8.3.4.2 Rising Risk of Diseases in Sweden
8.4 Asia-Pacific
8.4.1 Japan
8.4.1.1 Favorable Reimbursement Scenario
8.4.2 China
8.4.2.1 Rising Geriatric Population, Cvd Prevalence
8.4.3 India
8.4.3.1 Growing Applications and Rising Adoption of ECMO
8.4.4 Rest of Asia-Pacific
8.4.4.1 Prevalence of Cardiovascular and Respiratory Diseases in Australia
8.5 Rest of the World
8.5.1 Rising Adoption of ECMO as A Bridge to Heart and Lung Transplantation in Brazil
8.5.2 Conferences in UAE to Increase Awareness
9 Competitive Landscape (Page No. - 87)
9.1 Overview
9.2 Market Share Analysis
9.2.1 Getinge Group
9.2.2 Medtronic PLC
9.2.3 Livanova PLC
9.3 Competitive Situation and Trends
9.3.1 Approvals
9.3.2 Product Launches
9.3.3 Agreements & Partnerships
9.3.4 Expansions
9.3.5 Other Strategies
10 Company Profiles (Page No. - 96)
(Company at A Glance, Recent Financials, Products & Services, Strategies & Insights, & Recent Developments)*
10.1 Introduction
10.2 Getinge Group
10.3 Medtronic PLC
10.4 Livanova PLC
10.5 Terumo Corporation
10.6 Xenios AG (Acquired By Fresenius Medical Care AG & Co. KGaA)
10.7 Microport Scientific Corporation
10.8 Nipro Corporation
10.9 Origen Biomedical, Inc.
10.10 Alung Technologies, Inc.
10.11 Eurosets S.R.L.
*Details on Company at A Glance, Recent Financials, Products & Services, Strategies & Insights, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.
11 Appendix (Page No. - 119)
11.1 Discussion Guide
11.2 Other Developments
11.2.1 Livanova PLC
11.2.2 Xenios AG (Acquired By Fresenius Medical Care AG & Co. KGaA)
11.2.3 Alung Technologies, Inc.
11.3 Knowledge Store: Marketsandmarkets¡¯ Subscription Portal
11.4 Introducing RT: Real-Time Market Intelligence
11.4.1 Features and Benefits of RT:
11.5 Available Customizations
11.6 Related Reports
11.7 Author Details
List of Tables (78 Tables)
Table 1 Average Cost of Extracorporeal Membrane Oxygenation Machine in Various Countries
Table 2 Indicative List of Training Programs for ECMO By Hospitals
Table 3 Extracorporeal Membrane Oxygenation Machine Market Size, By Modality, 2014–2021 (USD Million)
Table 4 Venovenous ECMO Machine Market Size, By Region, 2014–2021 (USD Million)
Table 5 North America: Venovenous ECMO Machine Market Size, By Country, 2014–2021 (USD Million)
Table 6 Europe: Venovenous ECMO Machine Market Size, By Country/Region, 2014–2021 (USD Million)
Table 7 Asia-Pacific: Venovenous ECMO Machine Market Size, By Country/Region, 2014–2021 (USD Million)
Table 8 Venoarterial ECMO Machine Market Size, By Region, 2014–2021 (USD Million)
Table 9 North America: Venoarterial ECMO Machine Market Size, By Country, 2014–2021 (USD Million)
Table 10 Europe: Venoarterial Extracorporeal Membrane Oxygenation Machine Market Size, By Country/Region, 2014–2021 (USD Million)
Table 11 Asia-Pacific: Venoarterial ECMO Machine Market Size, By Country/Region, 2014–2021 (USD Million)
Table 12 Arteriovenous ECMO Machine Market Size, By Region, 2014–2021 (USD Million)
Table 13 North America: Arteriovenous ECMO Machine Market Size, By Country, 2014–2021 (USD Million)
Table 14 Europe: Arteriovenous ECMO Machine Market Size, By Country, 2014–2021 (USD Million)
Table 15 Asia-Pacific: Arteriovenous ECMO Machine Market Size, By Country/Region, 2014–2021 (USD Million)
Table 16 Extracorporeal Membrane Oxygenation Machine Market Size, By Application, 2014–2021 (USD Million)
Table 17 Extracorporeal Membrane Oxygenation Machine Market Size for Respiratory Applications, By Region, 2014–2021 (USD Million)
Table 18 North America: ECMO Machine Market Size for Respiratory Applications, By Country , 2014–2021 (USD Million)
Table 19 Europe: ECMO Machine Market Size for Respiratory Applications, By Region, 2014–2021 (USD Million)
Table 20 Asia-Pacific: Extracorporeal Membrane Oxygenation Machine Market Size for Respiratory Applications, By Region, 2014–2021 (USD Million)
Table 21 ECMO Machine Market Size for Respiratory Applications, By Type, 2014–2021 (USD Million)
Table 22 Neonates Receiving ECMO Support for Respiratory Applications
Table 23 Pediatric Patients Receiving ECMO Support for Respiratory Applications
Table 24 Lung Transplants in Adults ( Between January 1995 and June 2015)
Table 25 Adults Receiving ECMO Support for Respiratory Applications
Table 26 ECMO Machine Market Size for Cardiac Applications, By Region, 2014–2021 (USD Million)
Table 27 North America: Extracorporeal Membrane Oxygenation Machine Market Size for Cardiac Applications, By Country, 2014–2021 (USD Million)
Table 28 Europe: ECMO Machine Market for Cardiac Applications, By Country/Region, 2014–2021 (USD Million)
Table 29 Asia-Pacific: Extracorporeal Membrane Oxygenation Machine Market Size for Cardiac Applications, By Country/Region, 2014–2021 (USD Million)
Table 30 Extracorporeal Membrane Oxygenation Machine Market Size for Cardiac Applications, By Type, 2014–2021 (USD Million)
Table 31 Adults Receiving ECMO Support for Cardiac Applications
Table 32 Pediatric Patients Receiving ECMO Support for Cardiac Applications
Table 33 Neonates Receiving ECMO Support for Cardiac Applications
Table 34 ECMO Machine Market Size for ECPR Applications, By Region, 2014–2021 (USD Million)
Table 35 North America: ECMO Machine Market Size for ECPR Applications, By Country, 2014–2021 (USD Million)
Table 36 Europe: Extracorporeal Membrane Oxygenation Machine Market Size for ECPR Applications, By Country/Region, 2014–2021 (USD Million)
Table 37 Asia-Pacific: ECMO Machine Market Size for ECPR Applications, By Country/Region, 2014–2021 (USD Million)
Table 38 ECMO Market Size for ECPR Applications, By Type, 2014–2021 (USD Million)
Table 39 ECMO Machine Market Size, By Region, 2014-2021 (USD Million)
Table 40 North America: ECMO Machine Market Size, By Country, 2014-2021 (USD Million)
Table 41 North America: Extracorporeal Membrane Oxygenation Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 42 North America: ECMO Machine Market Size, By Application, 2014-2021 (USD Million)
Table 43 Indicative List of Research Articles Published in the U.S.
Table 44 U.S.: Extracorporeal Membrane Oxygenation Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 45 U.S.: ECMO Machine Market Size, By Application, 2014-2021 (USD Million)
Table 46 Canada: Extracorporeal Membrane Oxygenation Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 47 Canada: ECMO Machine Market Size, By Application, 2014-2021 (USD Million)
Table 48 Europe: ECMO Machine Market Size, By Country, 2014-2021 (USD Million)
Table 49 Europe: Extracorporeal Membrane Oxygenation Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 50 Europe: ECMO Machine Market Size, By Application, 2014-2021 (USD Million)
Table 51 Germany: ECMO Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 52 Germany: Extracorporeal Membrane Oxygenation Machine Market Size, By Application, 2014-2021 (USD Million)
Table 53 U.K.: ECMO Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 54 U.K.: Extracorporeal Membrane Oxygenation Machine Market Size, By Application, 2014-2021 (USD Million)
Table 55 France: ECMO Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 56 France: ECMO Machine Market Size, By Application, 2014-2021 (USD Million)
Table 57 RoE: Extracorporeal Membrane Oxygenation Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 58 RoE: ECMO Machine Market Size, By Application, 2014-2021 (USD Million)
Table 59 Asia-Pacific: Extracorporeal Membrane Oxygenation Machine Market Size, By Country, 2014-2021 (USD Million)
Table 60 Asia-Pacific: ECMO Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 61 Asia-Pacific: ECMO Machine Market Size, By Application, 2014-2021 (USD Million)
Table 62 Japan: ECMO Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 63 Japan: Extracorporeal Membrane Oxygenation Machine Market Size, By Application, 2014-2021 (USD Million)
Table 64 China: ECMO Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 65 China: ECMO Machine Market Size, By Application, 2014-2021 (USD Million)
Table 66 Indicative List of Hospitals Providing ECMO Treatment
Table 67 India: Extracorporeal Membrane Oxygenation Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 68 India: ECMO Machine Market Size, By Application, 2014-2021 (USD Million)
Table 69 RoAPAC: ECMO Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 70 RoAPAC: Extracorporeal Membrane Oxygenation Machine Market Size, By Application, 2014-2021 (USD Million)
Table 71 Indicative List of Conferences Related to ECMO
Table 72 RoW: ECMO Machine Market Size, By Modality, 2014-2021 (USD Million)
Table 73 RoW: ECMO Machine Market Size, By Application, 2014-2021 (USD Million)
Table 74 Approvals, 2013–2016
Table 75 Product Launches, 2013–2016
Table 76 Agreements & Partnerships, 2013–2016
Table 77 Expansions, 2013–2016
Table 78 Other Strategies, 2013–2016
List of Figures (31 Figures)
Figure 1 ECMO Machine Market Segmentation
Figure 2 Extracorporeal Membrane Oxygenation (ECMO) Machine Market: Research Methodology Steps
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Research Design
Figure 6 Data Triangulation Methodology
Figure 7 Venovenous Segment Dominates the ECMO Machine Market, By Modality, in 2016
Figure 8 Respiratory Applications Segment Accounts for the Largest Share of the ECMO Machine Market in 2016
Figure 9 Asia-Pacific to Register the Highest CAGR During the Forecast Period
Figure 10 Asia-Pacific Offers Significant Growth Opportunities for Players in the ECMO Machine Market
Figure 11 Venovenous Segment to Dominate the ECMO Machine Market in 2016
Figure 12 Respiratory Applications Will Continue to Dominate the ECMO Machine Market in 2021
Figure 13 Asia-Pacific to Register the Highest CAGR During the Forecast Period
Figure 14 Extracorporeal Membrane Oxygenation (ECMO) Machine Market: Drivers, Restraints, Opportunities, and Challenges
Figure 15 Number of Deaths From Cardiovascular and Respiratory Diseases Across the Globe, 2000 vs 2012 (Thousand Individuals)
Figure 16 Global Increase in the Number of ECMO Centers
Figure 17 North America to Command the Largest Share of the Market in 2016
Figure 18 North America: Market Snapshot
Figure 19 Europe: Market Snapshot
Figure 20 Asia-Pacific: Market Snapshot
Figure 21 Rest of the World (RoW): Market Snapshot
Figure 22 ECMO Machine Market Share, By Key Player, 2015
Figure 23 Key Developments in the ECMO Machine Market, 2013–2016
Figure 24 Battle for Market Share: Product Approvals Accounted for the Largest Share of the Total Developments Registered Between 2013 & 2016
Figure 25 Geographic Revenue Mix of the Prominent Players in the ECMO Machine Market
Figure 26 Getinge Group: Company Snapshot (2015)
Figure 27 Medtronic PLC: Company Snapshot (2015)
Figure 28 Livanova PLC: Company Snapshot (2014)
Figure 29 Terumo Corporation: Company Snapshot (2015)
Figure 30 Microport Scientific Corporation: Company Snapshot (2015)
Figure 31 Nipro Corporation: Company Snapshot (2015)
Title: Extracorporeal Membrane Oxygenation Machine Market by Modality (Veno-Arterial (VA), Veno-Venous (VV), Arterio-Venous (AV)), Application (Respiratory, Cardiac, Extracorporeal Cardiopulmonary Resuscitation (ECPR)), and Region - Analysis & Forecasts to 2021
The extracorporeal membrane oxygenation (ECMO) machine market is poised to reach USD 305.3 Million by 2021, at a CAGR of 4.3% during the forecast period of 2016 to 2021. The growth of the market can be contributed to the growing cardiovascular and respiratory diseases, rising adoption of ECMO as a bridge to lung transplantation, growing number of ECMO centers, conferences & training programs to increase awareness, and technological advancements. In addition, the rising geriatric population and the number of people suffering from diseases in populous countries such as India & China are factors that are expected to offer significant growth opportunities for ECMO systems. However, complications associated with extracorporeal membrane oxygenation machine such as bleeding, infections, and technical failures; along with high cost and lack of skilled professionals is a challenge to the market.
This report segments the market based on modality, application, and region. On the basis of modality, the market is segmented into venoarterial (VA), venovenous (VV), and arteriovenous (AV). The venovenous (VV) segment is expected to account for the largest share of the market in 2016. The large share of this segment is mainly attributed to the high incidence of respiratory failure, rising lung transplants, and technological advancements. The arteriovenous (AV) segment is projected to grow at the highest CAGR in the forecast period.
North America is estimated to account for the largest share of the global market, followed by Europe. The favorable reimbursement scenario, rising incidence of lung cancer, and the presence of a large number of ECMO centers in the U.S. is expected to boost the market for ECMO systems in North America.
A majority of the leading players in the market are pursuing the strategies of approvals, product launches, agreements & partnerships, expansions, and other strategies (rebranding, acquisition, website launch, product development, and market deployment).
The market is expected to witness the highest growth in the Asia-Pacific region, with emphasis on China, Japan, India, and the Rest of Asia-Pacific in the forecast period. Factors such as favorable reimbursement scenario in Japan, rising cardiovascular diseases in China, growing application and adoption of extracorporeal membrane oxygenation machine in India, and rising cardiopulmonary disorders in Australia are driving the growth of the market in this region.
In 2015, the key players of the extracorporeal membrane oxygenation machine market were Getinge Group (Sweden), Medtronic plc (Ireland), and LivaNova PLC (U.K.). These companies together contributed ~68.8% of the global market in 2015. The other players of the market are XENIOS AG (Germany), Terumo Corporation (Japan), MicroPort Scientific Corporation (China), NIPRO Corporation (Japan), OriGen Biomedical, Inc. (U.S.), ALung Technologies, Inc. (Germany), and EUROSETS S.r.l. (Italy).
Target Audience:
- ECMO Systems and related devices manufacturing companies
- Suppliers and distributors of ECMO systems and components
- Hospitals, ECMO centers, and medical colleges
- Teaching hospitals and academic medical centers (AMCs)
- Government bodies and regulatory authorities
- Business research and consulting service providers
- Venture capitalists
Scope of the Report:
This research report categorizes extracorporeal membrane oxygenation (ECMO) machine market into the following segments:
Extracorporeal Membrane Oxygenation (ECMO) Machine Market, by Modality
- Venoarterial (VA)
- Venovenous (VV)
- Arteriovenous (AV)
Extracorporeal Membrane Oxygenation (ECMO) Machine Market, by Application
- Respiratory
- Cardiac
- Extracorporeal Cardiopulmonary Resuscitation (ECPR)
Extracorporeal Membrane Oxygenation (ECMO) Machine Market, by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company¡¯s specific needs. The following customization option is available for the report:
Portfolio Assessment
- Product Matrix, which gives a detailed comparison of the product portfolios of the Top 3 companies
- Detailed analysis and profiling of additional market players (up to 3)